Alzheimer’s Disease (Mild to Moderate)
HAVE YOU OR SOMEONE YOU KNOW BEEN DIAGNOSED WITH ALZHEIMER’S DISEASE?
We are evaluating if a new investigational drug is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease.
- Be 55 to 85 years old
- Have a diagnosis of mild-to-moderate Alzheimer’s disease
- Have a reliable support person or caregiver
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.